Article Text


Basic science: Cardiovascular disease basic research
e0027 Growth differentiation factor 15 induce the proliferation of cardiac fibroblasts in a dose dependent manner
  1. Wang Yupeng,
  2. Xu Ming,
  3. Gao Wei


Objective Growth differentiation factor 15(GDF-15) is a member of Transforming growth factor-β superfamily which is one of the most important profibrotic protein released during Inflammation. It has been suggested that GDF-15 seems to be related to the remodelling processes by anti-hypertrophic in cardiomyocytes. Cardiac fibrosis is one part of the important pathology mechanisms during remodelling. It was still unknown whether GDF-15 could influence remodelling by modulating cardiac fibroblast proliferation and extracellular matrix (ECM) metabolism. Therefore, our study aims to investigate the expression and effects of GDF-15 in the fibroblasts.

Methods Primary myocardial fibroblasts were isolated and cultured from neonatal rats and divided into six groups subjected to different conditions: 10−6mol/l Endothelin-1 (ET-1), 10−5mol/l norepinephrine (NE), 3 ng/ml TGF-β1, 5 pg/ml rhGDF-15, 150 pg/ml rhGDF-15 and no stimuli. The expression of GDF-15 mRNA was detected by Realtime-PCR and the expression of GDF-15 protein was measured by Enzyme-linked Immunosorbent Assay (ELISA). The proliferation of fibroblast induced by rhGDF-15 was measured by 3-(4, 5-dimethylthiazol-2-yl) 2,5-diphenyl tetrazolium bromide (MTT) and Flow cytometry; the migration of fibroblast was shown by Scarification test. The level of phosphor- ERK was determined.

Results GDF-15 is upregulated in ET-1, NE and transforming growth factor (TGF)β1 group; the GDF-15 mRNA is respectively 1.21±0.03, 1.84±0.09, 1.95±0.39 folds of control group (respectively p<0.05, p<0.05, p<0.01); and protein in the supernatant is respectively 3.27±0.81 pg/ml, 3.55±0.20 pg/ml and 3.75±0.70 pg/ml, vs 0.41±0.17 pg/ml of control group (respectively p<0.05, p<0.001, p<0.01). rhGDF-15 (150 pg/ml) increased the OD value as compared to control group (0.56±0.03 vs 0.46±0.02, p<0.05), but 5 pg/ml rhGDF-15 did not (0.43±0.01 vs 0.46±0.02, p>0.05). rhGDF-15 (150 pg/ml) could also raise the cell in S phase nearly three times more than control group (9.62±1.17% vs 3.80±0.78%, p<0.01). The scarification test showed that rhGDF-15 could enhance the migration of fibroblast. The ERK was activated after treatment with rhGDF-15.

Conclusion GDF-15 is upregulated by ET-1, norepinephrine and TGF-β1 in myocardial fibroblasts. rhGDF-15 (150 pg/ml) could enhance the proliferation and migration of fibroblast, which may participate in the progression of myocardial fibrosis and thus was associated with ERK activation. Abbreviations: Growth differentiation factor 15(GDF-15), Extra cellular matrix (ECM), Endothelin-1(ET-1), norepinephrine (NE), Enzyme-linked Immunosorbent Assay (ELISA), 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyl tetrazolium bromide (MTT), Transforming growth factor (TGF), Extracellular Signal-Regulated Kinase (ERK).

  • Growth differentiation factor 15
  • cardiac fibroblasts

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.